Clinical trials
Leukemia, Myelomonocytic, Chronic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Astex Pharmaceuticals, Inc. | 2 |
| Janssen Research & Development, LLC | 2 |
| Pfizer | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Cogent Biosciences, Inc. | 1 |
| Ellipses Pharma | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Faron Pharmaceuticals Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 27 |
| Myelodysplastic Syndromes | 21 |
| Leukemia, Myeloid, Acute | 19 |
| Leukemia | 7 |
| Myeloproliferative Disorders | 6 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Congenital Abnormalities | 3 |
| Hematologic Diseases | 3 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.